MA28698B1 - Dicetopiperazines substituees utilisees comme antagonistes des oxytocines - Google Patents

Dicetopiperazines substituees utilisees comme antagonistes des oxytocines

Info

Publication number: MA28698B1
Authority: MA; Morocco
Prior art keywords: oxytocines; dicetopiperazines; antagonists; substituted; substituted dicetopiperazines
Prior art date: 2004-06-23

Application number

MA29584A

Other languages

English (en)

Inventor

Alan David Borthwick

Steven Leslie Sollis

Original Assignee

Glaxo Group Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-06-23

Filing date

2006-12-29

Publication date

2007-06-01

2006-12-29 Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd

2007-06-01 Publication of MA28698B1 publication Critical patent/MA28698B1/fr

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/06—Antiabortive agents; Labour repressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmacology & Pharmacy (AREA)
Engineering & Computer Science (AREA)
Animal Behavior & Ethology (AREA)
Chemical Kinetics & Catalysis (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Endocrinology (AREA)
Reproductive Health (AREA)
Diabetes (AREA)
Urology & Nephrology (AREA)
Gynecology & Obstetrics (AREA)
Pregnancy & Childbirth (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)

MA29584A 2004-06-23 2006-12-29 Dicetopiperazines substituees utilisees comme antagonistes des oxytocines MA28698B1 (fr)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GBGB0414092.7A GB0414092D0 (en)	2004-06-23	2004-06-23	Novel compounds

Publications (1)

Publication Number	Publication Date
MA28698B1 true MA28698B1 (fr)	2007-06-01

Family

ID=32800052

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
MA29584A MA28698B1 (fr)	2004-06-23	2006-12-29	Dicetopiperazines substituees utilisees comme antagonistes des oxytocines

Country Status (18)

Country	Link
US (1)	US20070208031A1 (fr)
EP (1)	EP1758893A1 (fr)
JP (1)	JP2008503535A (fr)
CN (1)	CN1989130A (fr)
AR (1)	AR049651A1 (fr)
AU (1)	AU2005256471A1 (fr)
BR (1)	BRPI0512359A (fr)
CA (1)	CA2571529A1 (fr)
GB (1)	GB0414092D0 (fr)
IL (1)	IL179912A0 (fr)
MA (1)	MA28698B1 (fr)
MX (1)	MXPA06014544A (fr)
NO (1)	NO20070157L (fr)
PE (1)	PE20060533A1 (fr)
RU (1)	RU2007102272A (fr)
TW (1)	TW200616635A (fr)
WO (1)	WO2006000400A1 (fr)
ZA (1)	ZA200610121B (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2641806B1 (fr) *	1989-01-16	1992-05-07	Diffusion Rech Tech Financ	Procede de stabilisation d'une aire de terrain meuble
GB0130677D0 (en) *	2001-12-21	2002-02-06	Glaxo Group Ltd	Medicaments and novel compounds
GB0314738D0 (en) *	2003-06-24	2003-07-30	Glaxo Group Ltd	Novel compounds
GB0414100D0 (en) *	2004-06-23	2004-07-28	Glaxo Group Ltd	Novel compounds
GB0414093D0 (en) *	2004-06-23	2004-07-28	Glaxo Group Ltd	Novel compounds
US7919581B2 (en)	2007-07-31	2011-04-05	Burnham Institute For Medical Research	Bi-dentate compounds as kinase inhibitors
US20100038143A1 (en) *	2008-08-14	2010-02-18	George Alexander Burnett	Drill cuttings treatment systems
WO2011051814A1 (fr)	2009-10-30	2011-05-05	Glaxo Group Limited	Nouvelles formes cristallines de (3r,6r) -3- (2, 3 -dihydro- 1h- inden- 2 -yl) - 1 - [ (1r) - 1 - (2, 6 - diméthyl - 3 - pyridinyl) - 2 - (4 -morpholinyl) -2-oxoéthyl] -6- [(1s) - 1 -méthylpropyl] -2,5- pipérazinedione
CN109305969B (zh) *	2017-07-27	2023-03-10	江苏恒瑞医药股份有限公司	哌嗪-2,5-二酮类衍生物、其制备方法及其在医药上的应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB0130677D0 (en) *	2001-12-21	2002-02-06	Glaxo Group Ltd	Medicaments and novel compounds
GB0414100D0 (en) *	2004-06-23	2004-07-28	Glaxo Group Ltd	Novel compounds

2004
- 2004-06-23 GB GBGB0414092.7A patent/GB0414092D0/en not_active Ceased
2005
- 2005-06-21 TW TW094120516A patent/TW200616635A/zh unknown
- 2005-06-21 JP JP2007517198A patent/JP2008503535A/ja active Pending
- 2005-06-21 CN CNA200580024634XA patent/CN1989130A/zh active Pending
- 2005-06-21 EP EP05755377A patent/EP1758893A1/fr not_active Withdrawn
- 2005-06-21 AR ARP050102538A patent/AR049651A1/es unknown
- 2005-06-21 AU AU2005256471A patent/AU2005256471A1/en not_active Abandoned
- 2005-06-21 CA CA002571529A patent/CA2571529A1/fr not_active Abandoned
- 2005-06-21 MX MXPA06014544A patent/MXPA06014544A/es not_active Application Discontinuation
- 2005-06-21 WO PCT/EP2005/006761 patent/WO2006000400A1/fr not_active Ceased
- 2005-06-21 BR BRPI0512359-3A patent/BRPI0512359A/pt not_active IP Right Cessation
- 2005-06-21 RU RU2007102272/04A patent/RU2007102272A/ru not_active Application Discontinuation
- 2005-06-21 US US11/630,097 patent/US20070208031A1/en not_active Abandoned
- 2005-06-22 PE PE2005000713A patent/PE20060533A1/es not_active Application Discontinuation
2006
- 2006-12-04 ZA ZA200610121A patent/ZA200610121B/xx unknown
- 2006-12-07 IL IL179912A patent/IL179912A0/en unknown
- 2006-12-29 MA MA29584A patent/MA28698B1/fr unknown
2007
- 2007-01-09 NO NO20070157A patent/NO20070157L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
WO2006000400A1 (fr)	2006-01-05
MXPA06014544A (es)	2007-03-12
GB0414092D0 (en)	2004-07-28
PE20060533A1 (es)	2006-09-03
US20070208031A1 (en)	2007-09-06
NO20070157L (no)	2007-01-23
RU2007102272A (ru)	2008-07-27
AR049651A1 (es)	2006-08-23
AU2005256471A1 (en)	2006-01-05
EP1758893A1 (fr)	2007-03-07
CN1989130A (zh)	2007-06-27
CA2571529A1 (fr)	2006-01-05
JP2008503535A (ja)	2008-02-07
BRPI0512359A (pt)	2008-03-04
TW200616635A (en)	2006-06-01
IL179912A0 (en)	2007-05-15
ZA200610121B (en)	2008-08-27

Publication	Publication Date	Title
CY2022001I1 (el)	2022-03-24	Παραγωγα του uk-2a
MA28822B1 (fr)	2007-08-01	Benzamides substitues trifluoromethyle comme inhibiteurs de kinase
LTC1761540I2 (lt)	2019-04-10	Chinazolinonai kaip žmogaus fosfatidilinozitol-3-kinazės-delta inhibitoriai
DK1720866T3 (da)	2011-11-21	Fremgangsmåde
EP1845849A4 (fr)	2014-08-13	Exosquelette des membres inferieurs
EP1874239A4 (fr)	2011-08-24	Exosquelette des membres inferieurs semi-motorise
ITMI20041252A1 (it)	2004-09-22	Composizioni perfluoroelastomeriche
DK1940839T3 (da)	2013-10-14	Pyridopyrimidione Inhibitors of P13Ka
EP2083864A4 (fr)	2010-12-08	Antagonistes de pcsk9
EP2083859A4 (fr)	2010-11-24	Antagonistes de pcsk9
EP2083860A4 (fr)	2010-05-26	Antagonistes de pcsk9
EP1788047A4 (fr)	2011-12-21	Composition hydrofuge/oleofuge
ZA200801394B (en)	2009-12-30	Novel sulphonylpyrroles as inhibitors of HDAC S novel sulphonylpyrroles
EP1812585A4 (fr)	2008-06-11	Bacteriophages comme agents selectifs
CY2013046I2 (el)	2015-11-04	Καινοτομος χρηση των αντισωματων αντι il-1bhta
EP1788874A4 (fr)	2010-11-24	Sels de 5-azacytidine
DK2402005T3 (da)	2021-03-15	Formuleringer med langvarig frigivelse af nalbuphin
DE602005016978D1 (de)	2009-11-12	Quecksilberfreisetzende Zusammensetzungen
NO20043305D0 (no)	2004-08-09	Preparation of lodixanol
NO20055643D0 (no)	2005-11-29	Preparation of lodixanol
EP1906944A4 (fr)	2010-08-04	Preparation de schisandrine b
EP1838906A4 (fr)	2015-07-01	Preparation de suspensions
PT1763520E (pt)	2009-03-23	Utilização de benzopiranonas trissubstituídas
MA28698B1 (fr)	2007-06-01	Dicetopiperazines substituees utilisees comme antagonistes des oxytocines
DE602005017191D1 (de)	2009-11-26	Geruchsreduzierte waschstück-zusammensetzung